feed,title,long_url,short_url
SeekingAlpha,VYNE Therapeutics gets enrollment underway in early-stage FMX114 atopic dermatitis study,https://seekingalpha.com/news/3754935,
SeekingAlpha,AT&T Stock: Yielding 8% And I Am Bullish Again As The Valuation Is Ridiculous,https://seekingalpha.com/article/4460291,
SeekingAlpha,Arlo: This Is The Right Time To Bet On This Consumer Tech Company,https://seekingalpha.com/article/4460490,
SeekingAlpha,"UiPath Stock: It's Still Expensive. So, Be Patient",https://seekingalpha.com/article/4460513,
